Milestone Pharmaceuticals Inc. — Director's Dealing 2022

Aug 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2022-07-05

Reporting Person: Pasternak Richard C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-05	Stock Option (right to buy)	$6.07	A	30000	Acquired	2032-07-05	Common Shares (30000)	Direct

Footnotes

F1: This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested
on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each
such vesting date.